New scan could spot hidden prostate cancer spread in men with gene mutations

NCT ID NCT05097274

Recruiting now Diagnosis Sponsor: Institute of Cancer Research, United Kingdom Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 34 times

Summary

This study aims to see if a type of PET-CT scan (FCH-PET-CT) is better than standard scans (bone scan and MRI/CT) at finding cancer that has spread outside the pelvis in men with prostate cancer who have specific gene mutations (like BRCA). About 50 men with these mutations will get both types of scans, and researchers will compare how well each detects metastases. The goal is to improve early detection and guide treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Cancer Genetics Unit, Royal Marsden Hospital
RECRUITING

London, Sutton, Surrey, SM2 5PT, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ATM GENE MUTATION BRCA MUTATION BRCA MUTATION CHEK2 GENE MUTATION HOXB13 GERMLINE MUTATION HOXB13 GERMLINE MUTATION MISMATCH REPAIR GENE MUTATION PALB2 GENE MUTATION PROSTATE CANCER